BRIEF-UK's MHRA Approves Novavax COVID-19 Vaccine For 12 To 17 Years Age Group

Reuters | London | Updated: 26-08-2022 15:49 IST | Created: 26-08-2022 15:48 IST
BRIEF-UK's MHRA Approves Novavax COVID-19 Vaccine For 12 To 17 Years Age Group
Representative image Image Credit: ANI
  • Country:
  • United Kingdom

MHRA:

* NOVAVAX COVID-19 VACCINE APPROVED FOR 12 TO 17S BY MHRA

* MHRA: MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY HAS CONCLUDED THAT NUVAXOVID IS SAFE AND EFFECTIVE IN 12 TO 17 YEARS AGE GROUP Further company coverage:

TRENDING

1
ROI-The energy transition is starting to feed itself: Maguire

ROI-The energy transition is starting to feed itself: Maguire

Global
2
Georgia block party shooting kills two, injures dozens

Georgia block party shooting kills two, injures dozens

Global
3
Brazil's Flavio Bolsonaro beats polls in presidential vote, faces Lula in runoff

Brazil's Flavio Bolsonaro beats polls in presidential vote, faces Lula in ru...

Global
4
Paraguay opposition candidate wins Asuncion mayor's race in gauge of 2028 vote

Paraguay opposition candidate wins Asuncion mayor's race in gauge of 2028 vo...

Global

PERSPECTIVES AND INSIGHTS

IVF Outcomes in Northern India: Examining Treatment Choices and Positive Pregnancy Tests

Beyond Megawatts: Why Clean Energy’s Real Test Is Creating Jobs, Skills and Better Livelihoods

Beyond English-Led AI: How Local Languages Could Unlock New Markets, Jobs and Public Services

From EVs to AI: Why the Future of Global Manufacturing May Depend on Small Businesses

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026